Position in KALV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,603,676
+$1,603,676 QoQ
Shares Held
79,666
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#66
of 182 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Mar 31, 2026CallValue
$44,286
CallShares
2,200
PutValue
$28,182
PutShares
1,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. KALV ranks #44 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
364,246 | $20,576,256 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
228,593 | $16,975,316 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
87,365 | $16,516,353 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,752 | $13,731,998 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
153,585 | $12,888,853 | |
| 6 | CELC |
Celcuity Inc.
|
105,688 | $12,063,228 | |
| 7 | INSM |
INSMED Inc
|
71,819 | $11,743,842 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
|
384,973 | $8,992,969 |
All Filings in KALV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,182 | 1,400 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $1,603,676 | 79,666 | Shares | Sole | 2026-05-13 | |
| 2026-03-31 | $44,286 | 2,200 | Call | Sole | 2026-05-13 | |
| 2025-06-30 | $241,927 | 21,400 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $1,130 | 100 | Put | Sole | 2025-08-13 | |
| 2025-03-31 | $2,875,317 | 249,161 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,267,783 | 267,743 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $1,426,852 | 120,308 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,198,417 | 97,830 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $562,180 | 58,378 | Shares | Sole | 2023-11-21 | |
| 2022-12-31 | $219,578 | 32,482 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,160,060 | 148,867 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,010,685 | 204,338 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $946,455 | 64,210 | Shares | Sole | 2022-05-27 | |
| 2020-06-30 | $201,779 | 16,676 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $159,120 | 20,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||